133 related articles for article (PubMed ID: 11558874)
41. Expression of selected T-cell antigens in the skin infiltration in primary cutaneous T-cell lymphomas.
Wojnowska D; Lecewicz-Toruń B; Chodorowska G; Juszkiewicz-Borowiec M; Skomra D
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():237-42. PubMed ID: 11977317
[TBL] [Abstract][Full Text] [Related]
42. Does fluorescence diagnosis have a role in follow up of response to therapy in mycosis fungoides?
Bosseila M; Mahgoub D; El-Sayed A; Salama D; Abd El-Moneim M; Al-Helf F
Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):595-602. PubMed ID: 25449155
[TBL] [Abstract][Full Text] [Related]
43. Clearance of a thick invasive squamous cell carcinoma after multiple treatments with topical photodynamic therapy.
Li Q; Gao T; Long HA; Ujiie H
Photomed Laser Surg; 2010 Oct; 28(5):703-6. PubMed ID: 20961235
[TBL] [Abstract][Full Text] [Related]
44. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application.
Schacht V; Szeimies RM; Abels C
Photochem Photobiol Sci; 2006 May; 5(5):452-8. PubMed ID: 16685321
[TBL] [Abstract][Full Text] [Related]
45. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial.
Rhodes LE; de Rie M; Enström Y; Groves R; Morken T; Goulden V; Wong GA; Grob JJ; Varma S; Wolf P
Arch Dermatol; 2004 Jan; 140(1):17-23. PubMed ID: 14732655
[TBL] [Abstract][Full Text] [Related]
46. Solitary plaque mycosis fungoides on the penis responding to topical imiquimod therapy.
Chiam LY; Chan YC
Br J Dermatol; 2007 Mar; 156(3):560-2. PubMed ID: 17300249
[TBL] [Abstract][Full Text] [Related]
47. Cutaneous expression of Thy-1 in mycosis fungoides.
Fivenson DP; Douglass MC; Nickoloff BJ
Am J Pathol; 1992 Dec; 141(6):1373-80. PubMed ID: 1281618
[TBL] [Abstract][Full Text] [Related]
48. Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study.
Severson KJ; Cumsky HJL; Brumfiel CM; Janeczek MC; Ginos BF; Kosiorek HE; Besch-Stokes J; Patel MH; Rule WG; DiCaudo DJ; Rosenthal AC; Pittelkow MR; Mangold AR
J Am Acad Dermatol; 2021 Oct; 85(4):969-971. PubMed ID: 33493572
[No Abstract] [Full Text] [Related]
49. Photodynamic therapy in mycosis fungoides.
Fernández-Guarino M; Jaén-Olasolo P
Actas Dermosifiliogr; 2013 Jun; 104(5):393-9. PubMed ID: 23664412
[TBL] [Abstract][Full Text] [Related]
50. Extracorporeal photochemotherapy induces apoptosis of infiltrating lymphoid cells in patients with mycosis fungoides in early stages. A quantitative histological study.
Miracco C; Rubegni P; De Aloe G; D'Ascenzo G; Mazzatenta C; De Santi MM; Fimiani M
Br J Dermatol; 1997 Oct; 137(4):549-57. PubMed ID: 9390330
[TBL] [Abstract][Full Text] [Related]
51. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.
Morton C; Horn M; Leman J; Tack B; Bedane C; Tjioe M; Ibbotson S; Khemis A; Wolf P
Arch Dermatol; 2006 Jun; 142(6):729-35. PubMed ID: 16785375
[TBL] [Abstract][Full Text] [Related]
52. The effect of psoralen plus ultraviolet A in vitro in HUT-78 enhances by 5-aminolevulinic acid.
Akita Y; Watanabe D; Yanagishita T; Kuhara T; Kawamura C; Masuda Y; Kawada M; Nakaseko H; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2007; 23(2-3):95-7. PubMed ID: 17523931
[TBL] [Abstract][Full Text] [Related]
53. The cellular microenvironment and neoplastic population in mycosis fungoides skin lesions: a clinicopathological correlation.
Iliadis A; Koletsa T; Patsatsi A; Georgiou E; Sotiriadis D; Kostopoulos I
Eur J Dermatol; 2016 Dec; 26(6):566-571. PubMed ID: 27545221
[TBL] [Abstract][Full Text] [Related]
54. Huge Bowen's disease: a pitfall of topical photodynamic therapy.
Park JY; Kim SK; Cho KH; Kim YC
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):546-8. PubMed ID: 24284109
[TBL] [Abstract][Full Text] [Related]
55. Photochemotherapy for mycosis fungoides.
Roenigk HH
Arch Dermatol; 1977 Aug; 113(8):1047-51. PubMed ID: 889332
[TBL] [Abstract][Full Text] [Related]
56. Recurrence rate of basal cell carcinoma after topical aminolevulinic acid-based photodynamic therapy.
Naidenov N; Dencheva R; Tsankov N
Acta Dermatovenerol Croat; 2004; 12(3):157-61. PubMed ID: 15369639
[TBL] [Abstract][Full Text] [Related]
57. Folliculotropic mycosis fungoides: clinicopathological analysis of 17 patients.
Marschalkó M; Erős N; Kontár O; Hidvégi B; Telek J; Hársing J; Jókai H; Bottlik G; Rajnai H; Szepesi Á; Matolcsy A; Kárpáti S; Csomor J
J Eur Acad Dermatol Venereol; 2015 May; 29(5):964-72. PubMed ID: 25406034
[TBL] [Abstract][Full Text] [Related]
58. Lymphomatoid papulosis associated with plaque-stage and granulomatous mycosis fungoides.
Kardashian JL; Zackheim HS; Egbert BM
Arch Dermatol; 1985 Sep; 121(9):1175-80. PubMed ID: 4037844
[TBL] [Abstract][Full Text] [Related]
59. New proposal for the treatment of nodular basal cell carcinoma with intralesional 5-aminolevulinic acid.
Cappugi P; Mavilia L; Campolmi P; Reali EF; Mori M; Rossi R
J Chemother; 2004 Oct; 16(5):491-3. PubMed ID: 15565918
[TBL] [Abstract][Full Text] [Related]
60. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
